Related Experiment Videos
Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical
J Andreas Karas1, Jonathan Edgeworth2
1Shionogi B.V. London, 33 Kingsway, Holborn, London WC2B 6UF, UK.
Jac-Antimicrobial Resistance
|July 5, 2021
Abstract:
The video in this section is a copy of a recorded webinar organized by Shionogi to launch cefiderocol to the UK market in September 2020. Dr Andreas Karas presents the key clinical data for this new antibiotic for MDR Gram-negative infections, followed by reflections from Professor Jonathan Edgeworth on the potential use of the new agent in UK clinical practice. Included in the latter is a case study example of a compassionate use case using cefiderocol.